RecruitingNCT06874868

Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

Assessment of Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder


Sponsor

University of Coimbra

Enrollment

50 participants

Start Date

Sep 15, 2024

Study Type

OBSERVATIONAL

Summary

t is recognized that cortisol, a hormone produced by the adrenal glands, is a marker that is elevated in patients with psychological disorders, particularly anxiety. On the other hand, Temporomandibular Disorders (TMD) are a condition with a multifactorial etiology, in which emotional disturbances play a crucial role. Therefore, the aim of this study is to evaluate whether patients with TMD have higher levels of salivary cortisol compared to the general population. Initially, an assessment will be conducted using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) protocol to determine whether the patient suffer of any kind of Temporomandibular Disorder. Based on the results, individuals will be classified into two groups: the study group, consisting of patients with TMD, and the control group, composed of individuals without the disorder. Those who agree to participate will be required to sign an informed consent form. Subsequently, a saliva sample will be collected for analysis.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients who attend the dental clinic of the Faculty of Medicine of University of Coimbra

Exclusion Criteria1

  • Pregnant women, minors and non-autonomous individuals

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Faculty of Medicine of University of Coimbra

Coimbra, Coimbra District, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06874868